Publicaciones (78) Publicaciones de FRANCISCO JAVIER CAPOTE HUELVA

2022

  1. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice

    International Journal of Hematology, Vol. 116, Núm. 3, pp. 381-392

2021

  1. Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

    Annals of Hematology, Vol. 100, Núm. 4, pp. 1023-1029

2019

  1. Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

    Cancer Medicine, Vol. 8, Núm. 16, pp. 6955-6966

2018

  1. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

    The Lancet Oncology, Vol. 19, Núm. 11, pp. 1449-1458

  2. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 18, Núm. 10, pp. e401-e419

  3. Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation

    Seminars in Hematology, Vol. 55, Núm. 4, pp. 189-196

2017

  1. Role of 18F-FDG PET/CT in primary brain lymphoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 5, pp. 298-303

2016

  1. Gamma glutamyl transferase in 1744 patients with obstructive sleep apnea

    Sleep and Breathing

2015

  1. Efficacy of continuous positive airway pressure treatment on 5-year survival in patients with ischaemic stroke and obstructive sleep apnea: A randomized controlled trial

    Journal of Sleep Research, Vol. 24, Núm. 1, pp. 47-53

  2. Efficacy of home single-channel nasal pressure for recommending continuous positive airway pressure treatment in sleep apnea

    Sleep, Vol. 38, Núm. 1, pp. 13-21

  3. Follow-up monoclonal gammopathy of undetermined significance in kidney transplant

    Transplantation Proceedings

  4. Gamma glutamyl transferase and oxidative stress in obstructive sleep apnea: a study in 1744 patients

    Sleep and Breathing, Vol. 19, Núm. 3, pp. 883-890

  5. Obstructive sleep apnoea syndrome, endothelial function and markers of endothelialization. Changes after CPAP

    PLoS ONE, Vol. 10, Núm. 3

  6. Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea Blood Pressure Response to Continuous Positive Airway Pressure Treatment

    Journal of the American College of Cardiology, Vol. 66, Núm. 9, pp. 1023-1032

  7. Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma

    European Journal of Haematology, Vol. 94, Núm. 1, pp. 23-30

  8. Vasculopatía oclusiva por crioglobulinemia tipo I en mieloma múltiple IgG lambda

    Revista Clinica Espanola, Vol. 215, Núm. 5, pp. e39-e42

2014

  1. Diagnóstico diferencial de las complicaciones víricas del paciente inmunodeprimido sin infección por el VIH

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 50, pp. 2982-2986

  2. Diagnóstico diferencial de las complicaciones víricas del paciente inmunodeprimido sin infección por el VIH

    Medicine (Spain), Vol. 11, Núm. 50, pp. 2982-2986

  3. Effectiveness of home single-channel nasal pressure for sleep apnea diagnosis

    Sleep, Vol. 37, Núm. 12, pp. 1953-1961B

2013

  1. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

    Medical Mycology, Vol. 51, Núm. 2, pp. 150-154